{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:19:07Z","timestamp":1784953147715,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Deep brain stimulation (DBS) is a well-established treatment option for select patients with Parkinson\u2019s Disease (PD). However, response to DBS varies, therefore, the ability to predict who will have better outcomes can aid patient selection. Some PD-related monogenic mutations have been reported among factors that influence response to DBS. However, monogenic disease accounts for only a minority of patients with PD. The polygenic risk score (PRS) is an indication of cumulative genetic risk for disease. The PRS in PD has also been correlated with age of onset and symptom progression, but it is unknown whether correlations exist between PRS and DBS response. Here, we performed a pilot study to look for any such correlation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a retrospective analysis of 33 PD patients from the NIH PD Clinic and 13 patients from the Parkinson\u2019s Progression Markers Initiative database who had genetic testing and underwent bilateral subthalamic nucleus DBS surgery and clinical follow-up. A PD-specific PRS was calculated for all 46 patients based on the 90 susceptibility variants identified in the latest PD genome-wide association study. We tested associations between PRS and pre- and post-surgery motor and cognitive measures using multiple regression analysis for up to two years after surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Changes in scores on the Beck Depression Inventory (BDI) were not correlated with PRS when derived from all susceptibility variants, however, when removing pathogenic and high-risk carriers from the calculation, higher PRS was significantly associated with greater reduction in BDI score at 3\u00a0months and with similar trend 24\u00a0months after DBS. PRS was not a significant predictor of Unified Parkinson\u2019s Disease Rating Scale, Dementia Rating Scale, or phenomic and semantic fluency outcomes at 3- and 24-months after DBS surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This exploratory study suggests that PRS may predict degree of improvement in depressive symptoms after DBS, though was not predictive of motor and other cognitive outcomes after DBS. Additionally, PRS may be most relevant in predicting DBS outcomes in patients lacking pathogenic or high-risk PD variants. However, this was a small preliminary study and response to DBS treatment is multifactorial, therefore, more standardized high-powered studies are needed.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-023-03188-5","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T11:07:39Z","timestamp":1680606459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association of polygenic risk score with response to deep brain stimulation in Parkinson\u2019s disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Esther","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bandres-Ciga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Blauwendraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Dustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2663-6766","authenticated-orcid":false,"given":"Debra","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"issue":"10","key":"3188_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1586\/14737175.2015.1081815","volume":"15","author":"AA Bari","year":"2015","unstructured":"Bari AA, Fasano A, Munhoz RP, Lozano AM. Improving outcomes of subthalamic nucleus deep brain stimulation in Parkinson\u2019s disease. Expert Rev Neurother. 2015;15(10):1151\u201360.","journal-title":"Expert Rev Neurother"},{"issue":"S14","key":"3188_CR2","doi-asserted-by":"publisher","first-page":"S290","DOI":"10.1002\/mds.20962","volume":"21","author":"G Kleiner-Fisman","year":"2006","unstructured":"Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord. 2006;21(S14):S290-304.","journal-title":"Mov Disord"},{"issue":"2","key":"3188_CR3","doi-asserted-by":"publisher","first-page":"e187800","DOI":"10.1001\/jamanetworkopen.2018.7800","volume":"2","author":"CA Artusi","year":"2019","unstructured":"Artusi CA, Dwivedi AK, Romagnolo A, Pal G, Kauffman M, Mata I, et al. Association of subthalamic deep brain stimulation with motor, functional, and pharmacologic outcomes in patients with monogenic Parkinson disease. JAMA Netw Open. 2019;2(2):e187800.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"3188_CR4","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.26302","volume":"91","author":"G Pal","year":"2022","unstructured":"Pal G, Mangone G, Hill EJ, Ouyang B, Liu Y, Lythe V, et al. Parkinson disease and subthalamic nucleus deep brain stimulation: Cognitive effects in GBA mutation carriers. Ann Neurol. 2022;91(3):424\u201335.","journal-title":"Ann Neurol"},{"issue":"2","key":"3188_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s00415-005-0638-x","volume":"252","author":"LM Romito","year":"2005","unstructured":"Romito LM, Contarino MF, Ghezzi D, Franzini A, Garavaglia B, Albanese A. High frequency stimulation of the subthalamic nucleus is efficacious in parkin disease. J Neurol. 2005;252(2):208\u201311.","journal-title":"J Neurol"},{"issue":"5","key":"3188_CR6","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/mds.21903","volume":"23","author":"E Lohmann","year":"2008","unstructured":"Lohmann E, Welter ML, Fraix V, Krack P, Lesage S, Laine S, et al. Are parkin patients particularly suited for deep-brain stimulation? Mov Disord. 2008;23(5):740\u20133.","journal-title":"Mov Disord"},{"issue":"2","key":"3188_CR7","doi-asserted-by":"publisher","first-page":"e187800","DOI":"10.1001\/jamanetworkopen.2018.7800","volume":"2","author":"CA Artusi","year":"2019","unstructured":"Artusi CA, Dwivedi AK, Romagnolo A, Pal G, Kauffman M, Mata I, et al. Association of subthalamic deep brain stimulation with motor, functional, and pharmacologic outcomes in patients with monogenic parkinson disease: a systematic review and meta-analysis. JAMA Netw Open. 2019;2(2):e187800.","journal-title":"JAMA Netw Open"},{"issue":"12","key":"3188_CR8","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: A meta-analysis of genome-wide association studies. The Lancet Neurology. 2019;18(12):1091\u2013102.","journal-title":"The Lancet Neurology"},{"issue":"4","key":"3188_CR9","doi-asserted-by":"publisher","first-page":"e348","DOI":"10.1212\/NXG.0000000000000348","volume":"5","author":"H Iwaki","year":"2019","unstructured":"Iwaki H, Blauwendraat C, Leonard HL, Liu G, Maple-Gr\u00f8dem J, Corvol J-C, et al. Genetic risk of Parkinson disease and progression: An analysis of 13 longitudinal cohorts. Neurol Genet. 2019;5(4):e348.","journal-title":"Neurol Genet"},{"key":"3188_CR10","doi-asserted-by":"crossref","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. The Lancet. 2015;386(9996):896\u2013912.","DOI":"10.1016\/S0140-6736(14)61393-3"},{"key":"3188_CR11","unstructured":"Centers for Common Disease Genomics. https:\/\/www.genome.gov\/Funded-Programs-Projects\/NHGRI-Genome-Sequencing-Program\/Centers-for-Common-Disease-Genomics. Accessed 2 Jun 2022."},{"issue":"1","key":"3188_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang CC, Chow CC, Tellier LCAM, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience. 2015;4(1):7.","journal-title":"GigaScience"},{"issue":"22","key":"3188_CR13","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","volume":"26","author":"A Manichaikul","year":"2010","unstructured":"Manichaikul A, Mychaleckyj JC, Rich SS, Daly K, Sale M, Chen W-M. Robust relationship inference in genome-wide association studies. Bioinformatics. 2010;26(22):2867\u201373.","journal-title":"Bioinformatics"},{"issue":"7311","key":"3188_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nature09298","volume":"467","author":"The International HapMap 3 Consortium","year":"2010","unstructured":"The International HapMap 3 Consortium. Integrating common and rare genetic variation in diverse human populations. Nature. 2010;467(7311):52\u20138.","journal-title":"Nature"},{"key":"3188_CR15","doi-asserted-by":"publisher","first-page":"213.e3","DOI":"10.1016\/j.neurobiolaging.2016.06.001","volume":"45","author":"S Bandr\u00e9s-Ciga","year":"2016","unstructured":"Bandr\u00e9s-Ciga S, Price TR, Barrero FJ, Escamilla-Sevilla F, Pelegrina J, Arepalli S, et al. Genome-wide assessment of Parkinson\u2019s disease in a southern Spanish population. Neurobiol Aging. 2016;45:213.e3-213.e9.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"3188_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/gm13","volume":"1","author":"PD Stenson","year":"2009","unstructured":"Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, Thomas NS, et al. The human gene mutation database: 2008 update. Genome Medicine. 2009;1(1):13.","journal-title":"Genome Medicine"},{"issue":"D1","key":"3188_CR17","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. Clinvar: Public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42(D1):D980-5.","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"3188_CR18","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/mds.26435","volume":"30","author":"JG Hentz","year":"2015","unstructured":"Hentz JG, Mehta SH, Shill HA, Driver-Dunckley E, Beach TG, Adler CH. Simplified Conversion Method for Unified Parkinson\u2019s Disease Rating Scale Motor Examinations. Mov Disord Off J Mov Disord Soc. 2015;30(14):1967\u201370.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"15","key":"3188_CR19","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord. 2010;25(15):2649\u201353.","journal-title":"Mov Disord"},{"key":"3188_CR20","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing http:\/\/www.R-project.org (2013)."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03188-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03188-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03188-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T11:25:23Z","timestamp":1680607523000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03188-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3188"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03188-5","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,4]]},"assertion":[{"value":"4 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants gave informed consent to participate. The study was approved by the NIH Combined Neuroscience Institutional Review Board and local Institutional and Ethics Review Board for data collected from PPMI.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}